Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide-Reference-Cited by-同舟云学术

Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide

Published:2014-06-26 Issue:10 Volume:54 Page:2514-2522
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Morris Curly¹,de Wreede Liesbeth²,Scholten Marijke²,Brand Ronald²,van Biezen Anja²,Sureda Anna³,Dickmeiss Ebbe⁴,Trneny Marek⁵,Apperley Jane⁶,Chiusolo Patrizia⁷,van Imhoff Gustaaf W.⁸,Lenhoff Stig⁹,Martinelli Giovanni¹⁰,Hentrich Marcus¹¹,Pabst Thomas¹²,Onida Francesco¹³,Quinn Michael¹⁴,Kroger Nicolaus¹⁵,de Witte Theo¹⁶,Ruutu Tapani¹⁷,

Affiliation:

1. Centre for Cancer Research and Cell Biology; Queen's University of Belfast; Belfast UK

2. EBMT, Department of Medical Statistics and Bioinformatics; Leiden University Medical Center; Leiden The Netherlands

3. Department of Haematology, Addenbrooke's Hospital; Cambridge University; Cambridge UK

4. Cell Therapy Section, Department of Clinical Immunology; Rigshospitalet; Copenhagen Denmark

5. Charles University Hospital; Prague Czech Republic

6. Department of Haematology; Hammersmith Hospital; London UK

7. Istituto di Ematologia; Universita Cattolica S. Cuore; Rome Italy

8. Department of Hematology; University Medical Center Groningen; Groningen The Netherlands

9. Department of Hematology; University Hospital; Lund Sweden

10. European Institute of Oncology; Milan Italy

11. Klinikum Harlaching; Munich Germany

12. University Hospital Bern; Bern Switzerland

13. Department of Hematology and Oncology; University of Milan; Milan Italy

14. Department of Haematology; Belfast City Hospital; Belfast UK

15. Department of Stem Cell Transplantation; University Hospital Hamburg-Eppendorf; Hamburg Germany

16. Department of Hematology; Radboud University Nijmegen Medical Centre; Nijmegen The Netherlands

17. Department of Medicine; Helsinki University Central Hospital; Helsinki Finland

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.12759/fullpdf

Reference44 articles.

1. The EBMT activity survey 2009: trends over the past 5 years;Baldomero;Bone Marrow Transplant,2011

2. High-dose chemotherapy and autologous stem cell transplantation in multiple myeloma patients-single centre experience;Piatkowska-Jakubas;Przegl Lek,2011

3. Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis;Ferrara;Hematol Oncol,2011

4. Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients;O'Shea;Bone Marrow Transplant,2006

5. Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004;Nivison-Smith;Biol Blood Marrow Transplant,2007

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing cryopreservation strategies for scalable cell therapies: A comprehensive review with insights from iPSC‐derived therapies;Biotechnology Progress;2024-09-13

2. A deep eutectic solvent is an effective cryoprotective agent for platelets;Cryobiology;2024-09

3. Influence of dimethyl sulfoxide on membrane fluidity under rapid supercooling;The European Physical Journal Special Topics;2024-08-22

4. Pros and Cons of Cryopreserving Allogeneic Stem Cell Products;Cells;2024-03-21

5. Development of a Me2SO-free cryopreservation medium and its long-term cryoprotection on the CAR-NK cells;Cryobiology;2024-03